GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Cash-to-Debt

Prenetics Global (Prenetics Global) Cash-to-Debt

: 13.09 (As of Sep. 2023)
View and export this data going back to 2022. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Prenetics Global's cash to debt ratio for the quarter that ended in Sep. 2023 was 13.09.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Prenetics Global could pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Prenetics Global's Cash-to-Debt or its related term are showing as below:

PRE' s Cash-to-Debt Range Over the Past 10 Years
Min: 2.63   Med: 12.06   Max: 31.62
Current: 13.09

During the past 4 years, Prenetics Global's highest Cash to Debt Ratio was 31.62. The lowest was 2.63. And the median was 12.06.

PRE's Cash-to-Debt is ranked better than
81.12% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.44 vs PRE: 13.09

Prenetics Global Cash-to-Debt Historical Data

The historical data trend for Prenetics Global's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Cash-to-Debt
N/A 8.68 8.58 24.71

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.06 24.71 28.70 31.62 13.09

Competitive Comparison

For the Diagnostics & Research subindustry, Prenetics Global's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global Cash-to-Debt Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Prenetics Global's Cash-to-Debt falls into.



Prenetics Global Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Prenetics Global's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Prenetics Global's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global  (NAS:PRE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Prenetics Global Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.